Breaking News - The Fly

Open Search

EBS

Emergent BioSolutions

$

()

Emergent BioSolutions continues to broaden access of NARCAN nasal spray

EBS

3/28/2024 - 08:22am

Emergent BioSolutions receives NAI status for Baltimore Bayview facility

EBS

3/25/2024 - 08:38am

Emergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 report

EBS

3/7/2024 - 10:14am

Benchmark gets more bullish on Emergent BioSolutions, upgrades shares

EBS

3/7/2024 - 10:11am

Emergent BioSolutions sees Q1 revenue $200M-$250M, consensus $185.4M

EBS

3/6/2024 - 17:07pm

Emergent BioSolutions sees FY24 revenue $900M-$1.1B, consensus $1.18B

EBS

3/6/2024 - 17:06pm

Emergent BioSolutions reports Q4 EPS (77c), consensus (19c)

EBS

3/6/2024 - 17:04pm

Emergent BioSolutions options imply 36.4% move in share price post-earnings

EBS

3/6/2024 - 14:04pm

Emergent BioSolutions options imply 25.1% move in share price post-earnings

EBS

3/4/2024 - 14:34pm

Biotech Alert: Searches spiking for these stocks today

RAPT , EBS , EVGN

…

2/23/2024 - 11:04am

Emergent BioSolutions appoints Papa as new president, CEO

EBS , BLCO

2/21/2024 - 07:15am

Emergent extending shelf-life of newly manufactured NARCAN, FDA says

EBS

1/17/2024 - 11:00am

Emergent BioSolutions awarded procurement contract valued up to $235.8M

EBS

1/11/2024 - 08:03am

Emergent BioSolutions receives $75M anthrax vaccine contract from BARDA

EBS

11/28/2023 - 07:02am

Emergent BioSolutions receives non-compliance notice from NYSE

EBS

11/24/2023 - 07:33am